ANDREW R. JORDAN

Insider Reports History

Location
Baltimore, MD
Signature
/s/ John J. Kirby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANDREW R. JORDAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aceragen, Inc. CHIEF STRATEGY OFFICER Common Stock 451,890 $230,464 $0.5100 17 Jan 2023 Direct
Aceragen, Inc. CHIEF STRATEGY OFFICER Stock Options (Right to Buy) 25,400 20 Jan 2023 Direct
Aceragen, Inc. CHIEF STRATEGY OFFICER Series Z Convertible Preferred Stock 0 17 Jan 2023 Direct

Insider Reports Filed by ANDREW R. JORDAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588923001858-jordan-andrew-r-2023-01-20 Aceragen, Inc. 20 Jan 2023 1 $0 4 CHIEF STRATEGY OFFICER 02 Feb 2023, 19:13
/report/000110465923005137-jordan-andrew-r-2023-01-17 Aceragen, Inc. 17 Jan 2023 2 $0 4 Chief Strategy Officer 19 Jan 2023, 20:47
/report/000141588923000766-jordan-andrew-r-2023-01-06 IDERA PHARMACEUTICALS, INC. 06 Jan 2023 2 -$52,490 4 CHIEF STRATEGY OFFICER 10 Jan 2023, 20:19
/report/000110465922104793-jordan-andrew-r-2022-09-28 IDERA PHARMACEUTICALS, INC. 28 Sep 2022 2 $0 4 Chief Strategy Officer 30 Sep 2022, 21:48
/report/000110465922104788-jordan-andrew-r-2022-09-28 IDERA PHARMACEUTICALS, INC. 28 Sep 2022 0 $0 3 Chief Strategy Officer 30 Sep 2022, 21:44